These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 25192942)
1. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array. Haigh O; Depelsenaire AC; Meliga SC; Yukiko SR; McMillan NA; Frazer IH; Kendall MA J Control Release; 2014 Nov; 194():148-56. PubMed ID: 25192942 [TBL] [Abstract][Full Text] [Related]
2. Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. Chen X; Kask AS; Crichton ML; McNeilly C; Yukiko S; Dong L; Marshak JO; Jarrahian C; Fernando GJ; Chen D; Koelle DM; Kendall MA J Control Release; 2010 Dec; 148(3):327-33. PubMed ID: 20850487 [TBL] [Abstract][Full Text] [Related]
3. Anionic amino acid-derived cationic lipid for siRNA delivery. Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256 [TBL] [Abstract][Full Text] [Related]
4. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. Chong RH; Gonzalez-Gonzalez E; Lara MF; Speaker TJ; Contag CH; Kaspar RL; Coulman SA; Hargest R; Birchall JC J Control Release; 2013 Mar; 166(3):211-9. PubMed ID: 23313112 [TBL] [Abstract][Full Text] [Related]
5. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957 [TBL] [Abstract][Full Text] [Related]
6. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. Zhang C; Tang N; Liu X; Liang W; Xu W; Torchilin VP J Control Release; 2006 May; 112(2):229-39. PubMed ID: 16545478 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of siRNA/anti-cancer drug delivery system for non-melanoma skin cancer. Part I: Development and gene silencing of JAK1siRNA/5-FU loaded liposome nanocomplexes. Aslan M; Ozturk S; Shahbazi R; Bozdemir Ö; Dilara Zeybek N; Vargel İ; Eroğlu İ; Ulubayram K Eur J Pharm Biopharm; 2024 Oct; 203():114432. PubMed ID: 39097115 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Kigasawa K; Kajimoto K; Hama S; Saito A; Kanamura K; Kogure K Int J Pharm; 2010 Jan; 383(1-2):157-60. PubMed ID: 19732811 [TBL] [Abstract][Full Text] [Related]
9. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. Watanabe T; Umehara T; Yasui F; Nakagawa S; Yano J; Ohgi T; Sonoke S; Satoh K; Inoue K; Yoshiba M; Kohara M J Hepatol; 2007 Dec; 47(6):744-50. PubMed ID: 17822798 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. Jose A; Labala S; Venuganti VV J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse. Takanashi M; Oikawa K; Sudo K; Tanaka M; Fujita K; Ishikawa A; Nakae S; Kaspar RL; Matsuzaki M; Kudo M; Kuroda M Gene Ther; 2009 Aug; 16(8):982-9. PubMed ID: 19474812 [TBL] [Abstract][Full Text] [Related]
12. Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis. Ibaraki H; Kanazawa T; Kurano T; Oogi C; Takashima Y; Seta Y Biol Pharm Bull; 2019; 42(7):1216-1225. PubMed ID: 31257297 [TBL] [Abstract][Full Text] [Related]
13. Transdermal Delivery of siRNA through Microneedle Array. Deng Y; Chen J; Zhao Y; Yan X; Zhang L; Choy K; Hu J; Sant HJ; Gale BK; Tang T Sci Rep; 2016 Feb; 6():21422. PubMed ID: 26888011 [TBL] [Abstract][Full Text] [Related]
14. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration. Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610 [TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment. Mendonça LS; Firmino F; Moreira JN; Pedroso de Lima MC; Simões S Bioconjug Chem; 2010 Jan; 21(1):157-68. PubMed ID: 20000596 [TBL] [Abstract][Full Text] [Related]
16. Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis. Komano Y; Yagi N; Onoue I; Kaneko K; Miyasaka N; Nanki T J Pharmacol Exp Ther; 2012 Jan; 340(1):109-13. PubMed ID: 21994423 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin. Lee WR; Shen SC; Zhuo RZ; Wang KC; Fang JY Hum Gene Ther; 2009 Jun; 20(6):580-8. PubMed ID: 19239381 [TBL] [Abstract][Full Text] [Related]
18. Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system. Beale G; Hollins AJ; Benboubetra M; Sohail M; Fox SP; Benter I; Akhtar S J Drug Target; 2003 Aug; 11(7):449-56. PubMed ID: 15203934 [TBL] [Abstract][Full Text] [Related]
19. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Chien PY; Wang J; Carbonaro D; Lei S; Miller B; Sheikh S; Ali SM; Ahmad MU; Ahmad I Cancer Gene Ther; 2005 Mar; 12(3):321-8. PubMed ID: 15578064 [TBL] [Abstract][Full Text] [Related]
20. Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes. Sonoke S; Ueda T; Fujiwara K; Sato Y; Takagaki K; Hirabayashi K; Ohgi T; Yano J Cancer Res; 2008 Nov; 68(21):8843-51. PubMed ID: 18974128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]